PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+19.43%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$2.97B
AUM Growth
+$2.97B
(-14%)
Cap. Flow
-$158M
Cap. Flow
% of AUM
-5.33%
Top 10 Holdings %
Top 10 Hldgs %
46.1%
Holding
105
New
9
Increased
22
Reduced
25
Closed
10
Top Buys
| 1 |
Immunovant
IMVT
|
$49.6M |
| 2 |
argenx
ARGX
|
$40.1M |
| 3 |
Apogee Therapeutics
APGE
|
$38.9M |
| 4 |
Revolution Medicines
RVMD
|
$36.6M |
| 5 |
Tango Therapeutics
TNGX
|
$27.2M |
Top Sells
| 1 |
Apellis Pharmaceuticals
APLS
|
$74M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$68.3M |
| 3 |
Vir Biotechnology
VIR
|
$48M |
| 4 |
Amylyx Pharmaceuticals
AMLX
|
$40M |
| 5 |
Illumina
ILMN
|
$27.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
BioXcel Therapeutics
BTAI
$52.7M
| – | – |
0
| – | – |
|
102
BioMarin Pharmaceuticals
BMRN
$11.3B
| – | – |
-263,207
| Closed | -$22.8M |
|
103
Arcutis Biotherapeutics
ARQT
$1.91B
| – | – |
0
| – | – |
|
|
104
Apellis Pharmaceuticals
APLS
$3.51B
| – | – |
-812,037
| Closed | -$74M |
|
105
Aclaris Therapeutics
ACRS
$223M
| – | – |
0
| – | – |
|